Class Actions Lawsuits
Product Liability

B. Braun Aesculap Knee Replacement Defective Device Lawsuit

B. Braun Aesculap Knee Replacement Defective Device Lawsuit — Product Liability class action lawsuit

Case Overview

The B. Braun Aesculap knee replacement lawsuit centers on allegations that the company designed and distributed knee replacement implants with critical manufacturing and design defects. According to the lawsuit, ceramic joints fail to bond properly with the cement used during implantation, leading to metallosis (metal allergies), early device failure, and the need for invasive revision surgeries. The company is accused of concealing these known defects from the FDA and continuing to market the device despite awareness of the risks.

The case was filed in California on behalf of 25 patients who have suffered severe pain, mobility issues, and medical complications as a result of the defective implants. Many patients have already undergone revision surgeries, while others anticipate future medical interventions. The lawsuit seeks compensation for medical expenses, lost wages, pain and suffering, and punitive damages for the company's alleged concealment of the defects.

Who May Qualify

Individuals who received a B. Braun Aesculap knee replacement implant and suffered complications including metallosis, early device failure, or required revision surgeries.

Frequently Asked Questions

What are the main problems with the B. Braun Aesculap knee replacement?

The primary defects include ceramic joints that fail to bond properly with cement during implantation, causing metallosis (metal allergies), early device failure, and the need for painful revision surgeries.

Can I join the B. Braun knee replacement lawsuit?

Yes, if you received a B. Braun Aesculap knee replacement and experienced complications such as metallosis, device failure, or required revision surgery, you may be eligible to join the lawsuit filed in California.

What compensation might I receive?

Potential compensation includes reimbursement for medical expenses, lost wages, pain and suffering damages, and possibly punitive damages if the jury finds evidence of willful misconduct by B. Braun.

Related Cases

Victoza (Liraglutide) Lawsuit: Vision Loss (NAION) Claims — Product Liability class action lawsuit

Victoza (Liraglutide) Lawsuit: Vision Loss (NAION) Claims

Current
Product Liability
Victoza (liraglutide) lawsuits claim that Novo Nordisk failed to warn patients about the risk of non-arteritic anterior ischemic optic neuropathy (NAION), a condition causing sudden vision loss. Users of the GLP-1 diabetes drug allege that the manufacturer did not adequately disclose the potential eye damage risks.
View Details
Saxenda Lawsuit — Product Liability class action lawsuit

Saxenda Lawsuit

Current
Product Liability
Saxenda (liraglutide), a weight-loss drug approved by the FDA in 2014, is subject to ongoing litigation over alleged inadequate warnings about serious side effects including pancreatic cancer, pancreatitis, thyroid cancer, and stomach paralysis. Novo Nordisk is being sued for failing to warn patients of these health risks associated with the drug.
View Details
Bard / Becton Dickinson PowerPort Implantable Port Catheter Fracture & Injury Litigation — Product Liability class action lawsuit

Bard / Becton Dickinson PowerPort Implantable Port Catheter Fracture & Injury Litigation

Current
Product Liability
Plaintiffs allege that Bard PowerPort implantable port catheters — used in cancer patients and others requiring long-term IV access — are defectively designed and prone to fracturing, migrating, and causing life-threatening injuries including cardiac injury, pulmonary embolism, and infection.
View Details